Curbstone Financial Management Corp Exact Sciences Corp Transaction History

Curbstone Financial Management Corp

$458 Million
Q3 2024

A detailed history of Curbstone Financial Management Corp transactions in Exact Sciences Corp stock. As of the latest transaction made, Curbstone Financial Management Corp holds 7,850 shares of EXAS stock, worth $536,626. This represents 0.12% of its overall portfolio holdings.

Number of Shares

7,850

Previous 15,830 50.41%

Holding current value

$536,626

Previous $668,000 20.06%

% of portfolio

0.12%

Previous 0.15%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 03, 2024	SELL	$42.43 - $70.83 $338,591 - $565,223	-7,980 Reduced 50.41%	7,850 $534,000
Q2 2024 Jul 03, 2024	BUY	$41.33 - $74.26 $8,266 - $14,852	200 Added 1.28%	15,830 $668,000
Q1 2024 Apr 09, 2024	SELL	$56.27 - $73.77 $36,575 - $47,950	-650 Reduced 3.99%	15,630 $1.08 Million
Q4 2023 Jan 08, 2024	BUY	$59.06 - $75.72 $53,154 - $68,148	900 Added 5.85%	16,280 $1.2 Million
Q2 2023 Jul 05, 2023	BUY	$62.68 - $95.05 $12,536 - $19,010	200 Added 1.32%	15,380 $1.44 Million
Q1 2023 May 12, 2023	BUY	$47.19 - $70.77 $58,987 - $88,462	1,250 Added 8.97%	15,180 $1.03 Million
Q4 2022 Jan 19, 2023	SELL	$30.35 - $53.15 $126,863 - $222,167	-4,180 Reduced 23.08%	13,930 $690,000
Q3 2022 Oct 05, 2022	SELL	$31.97 - $49.37 $78,326 - $120,956	-2,450 Reduced 11.92%	18,110 $588,000
Q2 2022 Aug 04, 2022	SELL	$35.61 - $76.23 $131,757 - $282,051	-3,700 Reduced 15.25%	20,560 $810,000
Q1 2022 Apr 18, 2022	BUY	$57.56 - $82.54 $22,448 - $32,190	390 Added 1.63%	24,260 $1.7 Million
Q3 2021 Oct 06, 2021	BUY	$90.24 - $124.05 $58,656 - $80,632	650 Added 2.8%	23,870 $2.28 Million
Q2 2021 Jul 09, 2021	BUY	$93.66 - $139.27 $115,201 - $171,302	1,230 Added 5.59%	23,220 $2.89 Million
Q1 2021 Apr 05, 2021	BUY	$116.57 - $155.01 $94,421 - $125,558	810 Added 3.82%	21,990 $2.9 Million
Q4 2020 Jan 14, 2021	SELL	$99.61 - $142.12 $24,902 - $35,530	-250 Reduced 1.17%	21,180 $2.81 Million
Q3 2020 Oct 02, 2020	BUY	$72.92 - $102.01 $20,417 - $28,562	280 Added 1.32%	21,430 $2.19 Million
Q2 2020 Jul 10, 2020	BUY	$55.75 - $92.75 $8,362 - $13,912	150 Added 0.71%	21,150 $1.84 Million
Q1 2020 Apr 20, 2020	SELL	$37.9 - $104.44 $17,813 - $49,086	-470 Reduced 2.19%	21,000 $1.22 Million
Q4 2019 Jan 10, 2020	BUY	$77.66 - $99.74 $1.67 Million - $2.14 Million	21,470 New	21,470 $1.99 Million

Others Institutions Holding EXAS

# of Institutions

610

Shares Held

166M

Call Options Held

1.93M

Put Options Held

1.23M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $12.1B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Curbstone Financial Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Curbstone Financial Management Corp with notifications on news.

Account

Curbstone Financial Management Corp Exact Sciences Corp Transaction History